The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...
Researchers at National Taiwan University have developed a modular platform to reprogram tumor-derived extracellular vesicles ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
Immunotherapy has fundamentally transformed oncology, establishing a new pillar of cancer treatment alongside surgery, chemotherapy, and radiation. While ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
10d
T cells gain superior memory through new reprogramming method, boosting cancer-fighting abilities
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...
A new platform enables fast, scalable protein evolution - opening the door to new therapies and diagnostics, and to predicting resistance mutations across many disease areas. (Nanowerk News) In ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Reprogrammable RNA nanoparticles activate only in cancer cells to deliver targeted gene-silencing therapy while avoiding off-target effects, immune activation, and unnecessary drug exposure. (Nanowerk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback